Medtronic Enters New Outcomes-Based Insulin Pump Deal With Aetna

The device-maker will be on the hook to provide rebates to the health insurer if its self-adjusting insulin pumps don't maintain patients in appropriate glucose ranges, under a newly inked agreement. Medtronic already has a similar arrangement with UnitedHealthcare.

More from Policy & Regulation

More from Medtech Insight